Introducing TERÅ™️

The next generation of RNA therapeutics

Harnessing the power of combinatorial chemistry and AI to transform RNA drug development into a programmable process.

bg-dna.pngbg-dna-m.pngbgo-blue.pngfire-lines.pnglungs.pnglungs-m.png

A digital molecule - a digital design

Utilising massively parallel combinatorial chemistry and AI algorithms to unleash the full power of RNA

RNA therapeutics are an emerging class of modalities that act in a software-like manner. These molecules are by nature digital, discrete, and highly specific. Their chemical topology naturally lends itself to combinatorial searches and AI algorithms, which become particularly powerful and predictive when combined with cost-effective DNA synthesis and sequencing technologies.


Mapping the universe of RNA chemistry

The chemical space of RNA molecules is vast. We cut through it using the force of AI.

Our platform leverages massively-parallel processes to map the chemical space and reveal the structure-activity relationship (SAR) of RNA molecules. Employing big data, we optimize every component of RNA molecules, including their safety, efficiency, and duration of effect.

Breathe easy

With hundreds of millions of respiratory disease patients in need of a cure, the lungs are the next frontier for RNAi therapeutics

While there are many broad applications for our platform, we are currently focused on developing the next generation of RNA therapeutics to reprogram disease-causing genetic circuits that are responsible for respiratory illnesses. In this process, we take a principled human genetics approach to our target selection, enabling our fully-programmable RNA molecules to precisely eliminate the root causes of such diseases.

Working with the best

We appreciate the interest that our valued partners and funders have found in our technologies.